Advertisement

Obesity-Related Comorbidities

  • Paola Fierabracci
  • Anna Tamberi
  • Ferruccio SantiniEmail author

Abstract

Obesity contributes to the development of many diseases that increase the risk of mortality and worsen the quality of life. Recent studies indicate that, relative to the normal weight category, the main contribution to excess mortality in obesity comes from higher levels of BMI, while overweight appears associated with significantly lower all-cause mortality. However, BMI does not take into account body composition and body distribution and it has been clearly established that the preferential accumulation of fat in the upper body and visceral districts is more harmful because it is associated with an increased risk of developing diabetes, dyslipidemia, and hypertension. This chapter will briefly discuss the main metabolic, cardiovascular, respiratory, psychiatric, osteoarticular, oncologic, and endocrine dysfunctions associated with obesity.

Keywords

Metabolic syndrome Osteoarthritis Respiratory dysfunctions Cancer Endocrine dysfunctions 

References

  1. 1.
    Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;2(309):71–82.CrossRefGoogle Scholar
  2. 2.
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3.PubMedCrossRefGoogle Scholar
  4. 4.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRefGoogle Scholar
  5. 5.
    Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237–52.PubMedGoogle Scholar
  6. 6.
    International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/metabolic-syndrome.
  7. 7.
    Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutrition, metabolism and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17:319–26.PubMedCrossRefGoogle Scholar
  8. 8.
    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation; International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation. 2009;20(120):1640–5.CrossRefGoogle Scholar
  9. 9.
    Proença AR, Sertié RA, Oliveira AC, Campaña AB, Caminhotto RO, Chimin P, Lima FB. New concepts in white adipose tissue physiology. Braz J Med Biol Res. 2014;47:192–205.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR. The key role of insulin resistance in the cardiometabolic syndrome. Am J Med Sci. 2005;330:290–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Petersen K, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;420:125–6.Google Scholar
  12. 12.
    Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168–73.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans: implications for the insulin-resistant state. Diabetes Care. 1996;19:390–3.PubMedCrossRefGoogle Scholar
  14. 14.
    Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36:232–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J. 1991;121:1274–82.PubMedCrossRefGoogle Scholar
  16. 16.
    Malhotra A, Kang BP, Cheung S, Opawumi D, Meggs LG. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes. 2001;50:1918–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Morse SA, Zhang R, Thakur V, Reisin E. Hypertension and the metabolic syndrome. Am J Med Sci. 2005;330:303–10.PubMedCrossRefGoogle Scholar
  18. 18.
    Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, Corrêa JW, Gagnon AM, Gomez-Sanchez CE, Gomez-Sanchez EP, Sorisky A, Ooi TC, Ruzicka M, Burns KD, Touyz RM. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012;59:1069–78.PubMedCrossRefGoogle Scholar
  19. 19.
    Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG, Fierabracci P, Marsili A, Talini E, Giannetti M, Biadi O, Balbarini A, Mariani M, Pinchera A. Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr. 2006;19:1063–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Di Bello V, Santini F, Di Cori A, Pucci A, Talini E, Palagi C, Delle Donne MG, Marsili A, Fierabracci P, Valeriano R, Scartabelli G, Giannetti M, Anselmino M, Pinchera A, Mariani M. Effects of bariatric surgery on early myocardial alterations in adult severely obese subjects. Cardiology. 2008;109:241–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;14(16):5286–96.CrossRefGoogle Scholar
  22. 22.
    Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis. 2010;28:162–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–49.PubMedCrossRefGoogle Scholar
  24. 24.
    Santini F, Giannetti M, Mazzeo S, Fierabracci P, Scartabelli G, Marsili A, Valeriano R, Pucci A, Anselmino M, Zampa V, Vitti P, Pinchera A. Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women. J Endocrinol Invest. 2007;30:104–10.PubMedCrossRefGoogle Scholar
  25. 25.
    Giannetti M, Piaggi P, Ceccarini G, Mazzeo S, Querci G, Fierabracci P, Salvetti G, Galli G, Ricco I, Martinelli S, Di Salvo C, Anselmino M, Landi A, Vitti P, Pinchera A, Santini F. Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. Int J Obes (Lond). 2012;36:336–41.CrossRefGoogle Scholar
  26. 26.
    Al Dabal L, Bahammam AS. Obesity hypoventilation syndrome. Ann Thorac Med. 2009;4:41–9.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–45.PubMedCrossRefGoogle Scholar
  28. 28.
    Palla A, Digiorgio M, Carpenè N, Rossi G, D'Amico I, Santini F, Pinchera A. Sleep apnea in morbidly obese patients: prevalence and clinical predictivity. Respiration. 2009;78:134–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol (1985). 2005;99:1592–9.CrossRefGoogle Scholar
  30. 30.
    Zamarron C, García Paz V, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med. 2008;19:390–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Lanfranco F, Motta G, Minetto MA, Baldi M, Balbo M, Ghigo E, Arvat E, Maccario M. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol. 2010;2010:474518.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbance in obesity versus sleep apnea: the importance of visceral obesity and insulin resistance. J Intern Med. 2003;254:32–44.PubMedCrossRefGoogle Scholar
  33. 33.
    Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnea: all pro-inflammatory states. Obes Rev. 2007;8:119–27.PubMedCrossRefGoogle Scholar
  34. 34.
    Knutson KL, Zhao X, Mattingly M, Galli G, Cizza G. Predictors of sleep disordered breathing in obese adults who are chronic short sleepers. Sleep Med. 2012;13:484–9.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Heo M, Pietrobelli A, Fontaine KR, Sirey JA, Faith MS. Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int J Obes (Lond). 2006;30:513–9.CrossRefGoogle Scholar
  36. 36.
    Mauri M, Calderone A, Fagiolini A, Santini F, Borri C, Oppo A, Romano A, Rinaldi S, Polini M, Lippi C, Pinchera A, Cassano GB. Psychiatric disorders and lifetime mood spectrum symptoms in early and late onset obesity. Obes Metab. 2008;4:99–105.Google Scholar
  37. 37.
    Cassidy K, Kotynia-English R, Acres J, Flicker L, Lautenshlager N, Almeida OP. Association between lifestyle factors and mental health measures among community-dwelling older women. Aust N Z J Psychiatry. 2004;38:940–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Mauri M, Rucci P, Calderone A, Santini F, Oppo A, Romano A, Rinaldi S, Armani A, Polini M, Pinchera A, Cassano GB. Axis I and II disorders and quality of life in bariatric surgery candidates. J Clin Psychiatry. 2008;69:295–301.Google Scholar
  39. 39.
    Vincent HK, Heywood K, Connelly J, Hurley RW. Obesity and weight loss in the treatment and prevention of osteoarthritis. PM R. 2012;4:S59–67.Google Scholar
  40. 40.
    Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999;15:523–6.PubMedCrossRefGoogle Scholar
  41. 41.
    De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P, Karason K, Karlsson J, Larsson B, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Carlsson LM. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653–62.PubMedCrossRefGoogle Scholar
  43. 43.
    Bray GA, Fisher DA, Chopra IJ. Relation of thyroid hormones to body-weight. Lancet. 1976;1:1206–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Fierabracci P, Pinchera A, Martinelli S, Scartabelli G, Salvetti G, Giannetti M, Pucci A, Galli G, Ricco I, Querci G, Rago T, Di Salvo C, Anselmino M, Vitti P, Santini F. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21:54–60.PubMedCrossRefGoogle Scholar
  45. 45.
    Ybarra J, Sánchez-Hernández J, Pérez A. Hypovitaminosis D and morbid obesity. Nurs Clin North Am. 2007;42:19–27.PubMedCrossRefGoogle Scholar
  46. 46.
    Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991;72:51–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E, Ghigo E. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Int J Obes Relat Metab Disord. 1997;21:27–32.PubMedCrossRefGoogle Scholar
  48. 48.
    Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93:4254–60.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003;13:113–70.PubMedCrossRefGoogle Scholar
  50. 50.
    Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P, Johnson W, Klibanski A, Miller KK. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol. 2010;163:185–91.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G. GH/IGF-I regulation in obesity–mechanisms and practical consequences in children and adults. Horm Res Paediatr. 2010;73:153–60.PubMedCrossRefGoogle Scholar
  52. 52.
    Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol. 2010;316:147–53.PubMedCrossRefGoogle Scholar
  53. 53.
    Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 1995;80:1407–15.PubMedGoogle Scholar
  54. 54.
    Belobrajdic DP, Frystyk J, Jeyaratnaganthan N, Espelund U, Flyvbjerg A, Clifton PM, Noakes M. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. Eur J Endocrinol. 2010;162:1075–82.PubMedCrossRefGoogle Scholar
  55. 55.
    Galli G, Pinchera A, Piaggi P, Fierabracci P, Giannetti M, Querci G, Scartabelli G, Manetti L, Ceccarini G, Martinelli S, Di Salvo C, Anselmino M, Bogazzi F, Landi A, Vitti P, Maffei M, Santini F. Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding. Obes Surg. 2012;22:1276–80.PubMedCrossRefGoogle Scholar
  56. 56.
    Bjorntorp P. Centralization of body fat. Chichester: Wiley; 2001.CrossRefGoogle Scholar
  57. 57.
    Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 1993;77:341–6.PubMedGoogle Scholar
  58. 58.
    Schiffman SS, Graham BG, Sattely-Miller EA, Peterson-Dancy M. Elevated and sustained desire for sweet taste in african-americans: a potential factor in the development of obesity. Nutrition. 2000;16:886–93.PubMedCrossRefGoogle Scholar
  59. 59.
    Björntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord. 2000;24 Suppl 2:S80–5.PubMedCrossRefGoogle Scholar
  60. 60.
    Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimirri F. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int J Obes Relat Metab Disord. 1999;23:419–24.PubMedCrossRefGoogle Scholar
  61. 61.
    Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G, Maccario M, Mantero F, Marugo M, Rotella CM, Vettor R, Study Group on Obesity of the Italian Society of Endocrinology. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab. 2002;87:166–75.PubMedCrossRefGoogle Scholar
  62. 62.
    Bale TL. Stress sensitivity and the development of affective disorders. Horm Behav. 2006;50:529–33.PubMedCrossRefGoogle Scholar
  63. 63.
    Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology. 2006;31:2188–96.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91:449–58.PubMedCrossRefGoogle Scholar
  65. 65.
    Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J Neuroendocrinol. 2002;14:506–13.PubMedCrossRefGoogle Scholar
  66. 66.
    Das UN. Obesity: genes, brain, gut, and environment. Nutrition. 2010;26:459–73.PubMedCrossRefGoogle Scholar
  67. 67.
    Gibson EL, Checkley S, Papadopoulos A, Poon L, Daley S, Wardle J. Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med. 1999;61:214–24.PubMedCrossRefGoogle Scholar
  68. 68.
    Slag MF, Ahmad M, Gannon MC, Nuttall FQ. Meal stimulation of cortisol secretion: a protein induced effect. Metabolism. 1981;30:1104–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Vicennati V, Ceroni L, Gagliardi L, Gambineri A, Pasquali R. Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes. J Clin Endocrinol Metab. 2002;87:3984–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Vicennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab. 2000;85:4093–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14:482–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Paola Fierabracci
    • 1
  • Anna Tamberi
    • 1
  • Ferruccio Santini
    • 1
    Email author
  1. 1.Obesity Center at the Endocrinology UnitUniversity Hospital of PisaPisaItaly

Personalised recommendations